Trial Profile
A 12-week, multicenter study to evaluate the efficacy and safety of orally administered valsartan/amlodipine combo based therapy vs amlodipine monotherapy in black patients with stage II hypertension.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Nov 2011
Price :
$35
*
At a glance
- Drugs Amlodipine/valsartan (Primary) ; Amlodipine
- Indications Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Novartis
- 07 Nov 2011 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
- 04 Jun 2007 Status changed from in progress to completed.
- 10 Jul 2006 New trial record.